Dr. Clark allegedly bought controlled substances for purposes unrelated to his profession and then kept and dealt the ...

The U.S. Attorney’s Office has reached a civil settlement with a Santa Teresa business owner over alleged violations of ...

Recovery Centers of America pays $2 million to settle allegations of mismanaging controlled substances and subpar treatment ...

The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.

Trump's decision to move marijuana to Schedule III could ease taxes and expand medical access, but industry leaders warn it ...

What began as a string of undercover drug buys in the northwest suburbs has ended with a 31-year-old Des Plaines man sitting ...

The organization agrees to pay $2M after federal officials allege violations of the controlled substance laws and false ...

President Trump is considering signing an executive order that would reschedule cannabis as a Schedule III drug. That's a bad ...

Cannabis ETFs post record weekly gains as Trump plans to reclassify marijuana as a less dangerous drug, signaling major ...

Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to ...

Cannabis stock extended premarket gains as President Donald Trump is expected to sign an executive order on marijuana ...

Bipartisan congressional lawmakers are weighing in on a potentially imminent decision by President Donald Trump to move ...